Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
Showing 101 - 120 results of 2,072 for search '(( significant decrease decrease ) OR ( significant progress decrease ))~', query time: 0.46s Refine Results
  1. 101
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  2. 102
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  3. 103
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  4. 104
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  5. 105
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  6. 106
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  7. 107
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  8. 108
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  9. 109
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  10. 110
    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603 (0.1–10 mg/kg/day, as indicated).

    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  11. 111
    DIO Mice Liver Staining.

    DIO Mice Liver Staining. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  12. 112
    Trends of peroxisome-related gene expression in liver tissue.

    Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  13. 113
    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).

    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  14. 114
    The body weight and cholesterol levels of the mice were recorded before the administration of the drug.

    The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  15. 115
    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combined with digital image analysis technique.

    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  16. 116
    The structures of T3 and Kylo-0603.

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  17. 117
    Synthesis process of Kylo-0603.

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  18. 118
    ESI-HRMS spectra for Kylo-0603.

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  19. 119
    General procedure for the synthesis of Kylo-0603.

    General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  20. 120
    Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.docx

    Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

    Published 2025
    Save to List
    Saved in:

Search Tools: